Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.
The Cure Starts Now has funded $24,784,877 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 159 grants at over 100 hospitals in 29 countries.
CONNECT Consortium - $278,619
$278,619.00
September 2021
Immuno-Modulation to Treat Poor-Prognosis Pediatric Brain Tumors
Institute of Cancer Research – $113,747
$113,747.00
September 2021
Co-Culture Disruptor Screens to Target Cell-Cell Interactions in DMG
Institute of Cancer Research – $498,716
$498,716.00
September 2021
Translating Mechanism to Patient Benefit for ACVR1-Mutant Diffuse Intrinsic Pontine Glioma (DIPG) - An International Connect Consortium Preclinical / Clinical
Sydney Children’s Hospital – $195,327
$195,327.00
September 2021
Phase I/II Study of Oral DFMO and AMXT1501 for DIPG/DMG
Children’s Hospital of Colorado – $200,000
$200,000.00
September 2021
Multimodality, Combination Treatment Strategy for DIPG/DMG
Children's Cancer Institute – $50,000
$50,000.00
September 2021
Developing Novel Combination Therapies for Diffuse Intrinsic Pontine Glioma
Cincinnati Children's Hospital – $200,000
$200,000.00
September 2021
Targeting Purine Synthesis and One Carbon Metabolism in DIPG
UPMC Children's Hospital – $50,000
$50,000.00
September 2021
The Role of QPRT and NAD Pathways in DIPG Treatment Resistance
University of Queensland Diamantina Institute – $100,000
$100,000.00
September 2021
Innovative Models of the Brain Microenvironment to Identify New Treatments for Medulloblastoma
Duke University Hospital – $50,000
$50,000.00
September 2021
Identifying Oncolytic Viral Therapy Resistance Mechanisms in Brain Tumors
Funding of PBTCF 2021: PBTC-059 - $25,000
$25,000.00
January 2021
Phase 1 Trial of Autologous HER2-specific CAR T cells in Pediatric Patients with Refractory or Recurrent Ependymoma
International DIPG/DMG Registry And Repository - $1,508,198
$1,508,198.00
December 2020
Children's Cancer Institute - $99,251
$99,251.00
September 2020
Discovering New Epigenetic Players in DIPG Oncogenesis
Northwestern Memorial Hospital - $110,000
$110,000.00
September 2020
Development of Histone Demethylase Inhibitor Against DIPG
The Hospital for Sick Children - $100,000
$100,000.00
September 2020
Methionne Deptrivation as a Therapeutic Strategy for Diffuse Intrinsic Pontine Glioma